Physician profile
John G Chenarides
NPI 1053311605
$749,757.48
in general payments reported to CMS, 2019-2025
18 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101K · 2020: $140K · 2021: $111K · 2022: $120K · 2023: $120K · 2024: $156K · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $270K · Education: $6,051 · Food and Beverage: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $270,000.00 |
| Education | $6,051.19 |
| Food and Beverage | $944.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $747,089.46 | 2019-2024 | Lifevest |
| Abbott Laboratories | $810.34 | 2019-2025 | Jot Dx, Aveir, Diamondback Coronary |
| Biosense Webster, INC. | $375.53 | 2019-2022 | |
| Medtronic, INC. | $320.74 | 2021-2025 | Mycarelink, Micra, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $301.37 | 2019-2025 | Avvigo Guidance System, Watchman |
| Pfizer INC. | $244.66 | 2019 | |
| Medtronic Vascular, INC. | $214.40 | 2019-2020 | |
| Elutia, INC. | $146.64 | 2021 | |
| Cardiva Medical, INC. | $45.88 | 2019-2024 | Ensoetm |
| Impulse Dynamics (USA) INC. | $38.59 | 2019-2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $30.83 | 2023 | Xarelto |
| Cook Medical LLC | $24.94 | 2020 | |
| W. L. Gore & Associates, INC. | $23.80 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.08 | 2023 | |
| Heartflow, INC. | $21.44 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $18.87 | 2023 | Venture |
| Amarin Pharma, INC. | $16.01 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Chenarides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.